• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评价 SLOG/TCI-III 儿科靶控输注系统在丙泊酚靶控输注中的应用。

Evaluation of SLOG/TCI-III pediatric system on target control infusion of propofol.

机构信息

Department of Pharmacy, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

出版信息

J Transl Med. 2011 Nov 1;9:187. doi: 10.1186/1479-5876-9-187.

DOI:10.1186/1479-5876-9-187
PMID:22044738
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3221635/
Abstract

BACKGROUND

The target-controlled infusion-III (SLOG/TCI-III) system was derived from a model set up by the local pediatric population for target control infusion of propofol.

METHODS

The current study aimed at evaluating the difference between target concentrations of propofol and performance, which was measured using the SLOG/TCI-III system in children. Thirty children fulfilling the I-II criteria according to American Society of Anesthesiology were enrolled in the study. The target plasma concentration of propofol was fed into the SLOG/TCI-III system and compared with the measured concentrations of propofol. Blood samples were collected and analyzed by high performance liquid chromatography with fluorescence detector. The performance error (PE) was determined for each measured blood propofol concentration. The performances of the TCI-III system were determined by the median performance error (MDPE), the median absolute performance error (MDAPE), and Wobble (the median absolute deviation of each PE from the MDPE), respectively.

RESULTS

Concentration against target concentration showed good linear correlation: concentration = 1.3428 target concentration - 0.2633 (r = 0.8667). The MDPE and MDAPE of the pediatric system were 10 and 22%, respectively, and the median value for Wobble was 24%. MDPE and MDAPE were less than 15 and 30%, respectively.

CONCLUSIONS

The performance of TCI-III system seems to be in the accepted limits for clinical practice in children.

摘要

背景

靶控输注-III(SLOG/TCI-III)系统源自针对儿童的丙泊酚靶控输注的本地儿科人群建立的模型。

方法

本研究旨在评估 SLOG/TCI-III 系统在儿童中测量的丙泊酚靶浓度与性能之间的差异。根据美国麻醉医师学会的 I-II 标准,本研究纳入了 30 名儿童。将丙泊酚的目标血浆浓度输入 SLOG/TCI-III 系统,并与测量的丙泊酚浓度进行比较。通过高效液相色谱法-荧光检测器采集和分析血样。确定每个测量的血丙泊酚浓度的性能误差(PE)。通过中位性能误差(MDPE)、中位绝对性能误差(MDAPE)和摆动(每个 PE 与 MDPE 的中位数绝对偏差),分别确定 TCI-III 系统的性能。

结果

浓度与目标浓度呈良好的线性相关:浓度=1.3428×目标浓度-0.2633(r=0.8667)。儿科系统的 MDPE 和 MDAPE 分别为 10%和 22%,中位摆动值为 24%。MDPE 和 MDAPE 分别小于 15%和 30%。

结论

TCI-III 系统的性能似乎在儿童临床实践的可接受范围内。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27a4/3221635/66c5b15c4cae/1479-5876-9-187-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27a4/3221635/ad6ca68a773a/1479-5876-9-187-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27a4/3221635/c8080ebbfb79/1479-5876-9-187-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27a4/3221635/66c5b15c4cae/1479-5876-9-187-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27a4/3221635/ad6ca68a773a/1479-5876-9-187-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27a4/3221635/c8080ebbfb79/1479-5876-9-187-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27a4/3221635/66c5b15c4cae/1479-5876-9-187-3.jpg

相似文献

1
Evaluation of SLOG/TCI-III pediatric system on target control infusion of propofol.评价 SLOG/TCI-III 儿科靶控输注系统在丙泊酚靶控输注中的应用。
J Transl Med. 2011 Nov 1;9:187. doi: 10.1186/1479-5876-9-187.
2
Predictive performance of 'Diprifusor' TCI system in patients during upper abdominal surgery under propofol/fentanyl anesthesia.“得普利麻”靶控输注系统在丙泊酚/芬太尼麻醉下上腹部手术患者中的预测性能
J Zhejiang Univ Sci B. 2005 Jan;6(1):43-8. doi: 10.1631/jzus.2005.B0043.
3
[Predictability and precision of "target-controlled infusion" (TCI) of propofol with the "Disoprifusor TCI" system].使用“得普利麻靶控输注系统”进行丙泊酚“靶控输注”(TCI)的可预测性与精确性
Anaesthesist. 1998 Aug;47(8):663-8. doi: 10.1007/s001010050611.
4
The performance of compartmental and physiologically based recirculatory pharmacokinetic models for propofol: a comparison using bolus, continuous, and target-controlled infusion data.隔室和基于生理的丙泊酚再循环药代动力学模型的性能:使用推注、连续和靶控输注数据的比较。
Anesth Analg. 2010 Aug;111(2):368-79. doi: 10.1213/ANE.0b013e3181bdcf5b. Epub 2009 Oct 27.
5
Predictive performance of computer-controlled infusion of remifentanil during propofol/remifentanil anaesthesia.丙泊酚/瑞芬太尼麻醉期间瑞芬太尼计算机控制输注的预测性能
Br J Anaesth. 2003 Feb;90(2):132-41. doi: 10.1093/bja/aeg046.
6
Performance of computer-controlled infusion of propofol: an evaluation of five pharmacokinetic parameter sets.丙泊酚计算机控制输注的性能:五种药代动力学参数集的评估
Anesth Analg. 1995 Dec;81(6):1275-82. doi: 10.1097/00000539-199512000-00026.
7
Accuracy of the 'Paedfusor' in children undergoing cardiac surgery or catheterization.“小儿输液泵”在接受心脏手术或心导管插入术患儿中的准确性。
Br J Anaesth. 2003 Oct;91(4):507-13. doi: 10.1093/bja/aeg220.
8
Concentrations of propofol in cerebral spinal fluid: target-controlled infusion.脑脊液中丙泊酚的浓度:靶控输注
Chin Med J (Engl). 2004 Feb;117(2):231-4.
9
Evaluation of bias in predicted and measured propofol concentrations during target-controlled infusions in obese Japanese patients: an open-label comparative study.肥胖日本患者靶控输注期间丙泊酚预测浓度与实测浓度偏差的评估:一项开放标签对照研究。
Eur J Anaesthesiol. 2014 Dec;31(12):701-7. doi: 10.1097/EJA.0000000000000154.
10
Clinical evaluation of target controlled infusion system for sufentanil administration.舒芬太尼靶控输注系统的临床评估。
Chin Med J (Engl). 2009 Oct 20;122(20):2503-8.

本文引用的文献

1
Clinical evaluation of a simultaneous closed-loop anaesthesia control system for depth of anaesthesia and neuromuscular blockade*.临床评估一种用于麻醉深度和神经肌肉阻滞的同步闭环麻醉控制系统*。
Anaesthesia. 2011 Dec;66(12):1112-20. doi: 10.1111/j.1365-2044.2011.06875.x. Epub 2011 Sep 23.
2
SITC/iSBTc Cancer Immunotherapy Biomarkers Resource Document: online resources and useful tools - a compass in the land of biomarker discovery.SITC/iSBTc 癌症免疫治疗生物标志物资源文件:在线资源和有用工具——在生物标志物发现的领域中的指南针。
J Transl Med. 2011 Sep 19;9:155. doi: 10.1186/1479-5876-9-155.
3
Preferential expression of potential markers for cancer stem cells in large cell neuroendocrine carcinoma of the lung. An FFPE proteomic study.
肺癌大细胞神经内分泌癌中癌症干细胞潜在标志物的优先表达。一项福尔马林固定石蜡包埋组织蛋白质组学研究。
J Clin Bioinforma. 2011 Sep 3;1(1):23. doi: 10.1186/2043-9113-1-23.
4
A filter-based feature selection approach for identifying potential biomarkers for lung cancer.一种基于过滤的特征选择方法,用于识别肺癌的潜在生物标志物。
J Clin Bioinforma. 2011 Mar 21;1(1):11. doi: 10.1186/2043-9113-1-11.
5
Moving towards high density clinical signature studies with a human proteome catalogue developing multiplexing mass spectrometry assay panels.随着人类蛋白质组目录开发多重质谱分析面板,迈向高密度临床特征研究。
J Clin Bioinforma. 2011 Feb 8;1(1):7. doi: 10.1186/2043-9113-1-7.
6
Bioinformatic-driven search for metabolic biomarkers in disease.基于生物信息学的疾病代谢生物标志物搜索
J Clin Bioinforma. 2011 Jan 20;1(1):2. doi: 10.1186/2043-9113-1-2.
7
Clinical bioinformatics: a new emerging science.临床生物信息学:一门新兴科学。
J Clin Bioinforma. 2011 Jan 20;1(1):1. doi: 10.1186/2043-9113-1-1.
8
Biomarkers in T cell therapy clinical trials.T 细胞治疗临床试验中的生物标志物。
J Transl Med. 2011 Aug 19;9:138. doi: 10.1186/1479-5876-9-138.
9
Mechanism-related circulating proteins as biomarkers for clinical outcome in patients with unresectable hepatocellular carcinoma receiving sunitinib.索坦治疗不可切除肝细胞癌患者的临床结局相关循环蛋白标志物的机制研究。
J Transl Med. 2011 Jul 25;9:120. doi: 10.1186/1479-5876-9-120.
10
Psoriasis: from bed to bench and back.银屑病:从临床到实验室再回归临床
Nat Biotechnol. 2011 Jul 11;29(7):563-6. doi: 10.1038/nbt.1906.